What Are Clinical Trials?
A clinical trial is a carefully designed research study conducted with human volunteers to answer specific questions about new medical treatments, interventions, or diagnostic methods. In the field of oncology, clinical trials are the primary way that researchers and doctors find new and better ways to prevent, diagnose, and treat cancer. Every cancer treatment that is considered “standard of care” today—from chemotherapy drugs to modern immunotherapies—was first shown to be safe and effective through a series of clinical trials.
These studies are not random experiments; they are conducted according to a strict scientific plan, called a protocol, that is designed to protect the safety of the participants and to produce reliable, high-quality data. In Turkey, clinical trials are conducted in major university hospitals and advanced cancer centers that have the specialized infrastructure, personnel, and ethical oversight required to carry out this important research according to both national regulations and international standards.
The Purpose of Cancer Clinical Trials
The overarching purpose of cancer clinical trials is to advance medical knowledge and improve patient outcomes. They are designed to answer specific scientific questions and to determine if a new treatment approach is more effective and/or has fewer side effects than the current standard treatment.
The goals of a cancer clinical trial can vary and may include:
- Testing a brand-new drug or therapy for the first time in humans.
- Evaluating a new combination of existing, approved treatments.
- Investigating a new way of giving a standard treatment (e.g., a different dose or schedule) to see if it is more effective or has fewer side effects.
- Studying new surgical or radiation therapy techniques.
- Finding new ways to manage the symptoms of cancer or the side effects of its treatment.
Participation in a clinical trial is a voluntary choice and offers patients the opportunity to receive a novel therapy while also contributing to the medical knowledge that will benefit future cancer patients.
Phases of Clinical Trials: A Step-by-Step Process
New cancer treatments are developed and tested in a logical, step-by-step process through a series of “phases.” Each phase is designed to answer a different set of questions.
- Phase I: Is it safe?
A Phase I trial is the first time a new treatment is tested in a small group of human volunteers. The primary goal is to evaluate the safety of the new drug, determine a safe dosage range, and identify any initial side effects. Participants in Phase I trials often have advanced cancer that has not responded to standard treatments. - Phase II: Does it work?
If a new treatment is found to be reasonably safe in Phase I, it moves to a Phase II trial. Here, the drug is given to a larger group of patients with a specific type of cancer to see if it has a measurable effect on the cancer (e.g., does it shrink tumors?). The safety of the drug continues to be closely monitored. - Phase III: Is it better?
If a treatment shows promise in Phase II, it progresses to a Phase III trial. This is a large-scale study, often involving hundreds or thousands of patients, sometimes across multiple countries. The main goal is to compare the new treatment against the current “standard of care” treatment. Patients are randomly assigned to receive either the new treatment (the investigational arm) or the standard treatment (the control arm). Phase III trials are the final step required before a new drug can be approved by regulatory authorities for widespread public use. - Phase IV: What else do we need to know?
Phase IV trials take place after a new drug has been approved and is available on the market. These studies are designed to monitor the drug’s long-term effectiveness and safety in a large, diverse population and to look for any rare or long-term side effects that may not have appeared in the earlier trials.
The Clinical Trial Team in Turkey
A clinical trial is managed by a dedicated team of healthcare professionals who are responsible for the patient’s care and the integrity of the research data.
- Principal Investigator (PI): This is the doctor (usually a medical oncologist) who leads the clinical trial at a specific hospital. They have overall responsibility for the study and the patients enrolled in it.
- Research Coordinator or Clinical Research Nurse: This is a key point of contact for the patient. They are a highly trained nurse or professional who helps to coordinate all aspects of the trial, including scheduling appointments, managing data, and ensuring that the study protocol is followed precisely. They are an invaluable resource for patients to answer questions and navigate the trial process.
- Other Members of the Oncology Team: The patient’s regular team of doctors, nurses, pharmacists, and other specialists continue to be involved in their overall care.
Ethical Oversight and Patient Protection
Patient safety is the highest priority in any clinical trial. In Turkey, as in other countries with advanced medical systems, clinical trials are subject to rigorous ethical and regulatory oversight to protect the rights and welfare of participants.
- Ethics Committees: Before a clinical trial can begin at a hospital, its protocol must be reviewed and approved by an independent Ethics Committee (also known as an Institutional Review Board or IRB). This committee is made up of doctors, scientists, and laypeople from the community. Their job is to ensure that the trial is scientifically sound, that the potential benefits outweigh the risks, and that patients are not exposed to unnecessary harm.
- Regulatory Authorities: All clinical trials must also be approved and are continuously monitored by national regulatory bodies, such as the Turkish Medicines and Medical Devices Agency (TİTCK).
- Informed Consent: This is a fundamental ethical principle and a critical part of the process, which is detailed further below.
Informed Consent: A Critical Step
No patient can be enrolled in a clinical trial without first going through a process called informed consent. This is not just a form to sign; it is an ongoing conversation. The research team will provide the patient with a detailed document that explains all aspects of the trial in clear, understandable language.
The informed consent document will cover:
- The purpose of the study.
- The procedures involved and the expected duration.
- The potential risks, side effects, and discomforts.
- The potential benefits (though benefits cannot be guaranteed).
- Alternative treatment options that are available outside of the trial.
- A clear statement that participation is completely voluntary and that the patient can choose to leave the trial at any time for any reason, without it affecting their right to receive standard medical care.
The patient is encouraged to take this document home, discuss it with their family and their regular doctor, and ask as many questions as they need to before making a decision.
Potential Benefits and Risks of Participation
Deciding whether to participate in a clinical trial involves weighing the potential benefits against the potential risks.
- Potential Benefits:
- Gaining access to a new and potentially highly effective treatment before it is widely available.
- Receiving expert medical care at a leading cancer center.
- Playing an active role in your own healthcare.
- Contributing to medical research that can help future generations of cancer patients.
- Potential Risks:
- The new treatment may not be more effective than the standard treatment.
- The new treatment may have unknown or unexpected side effects.
- Even if the treatment is effective for some, it may not work for every individual.
- Participating in a trial may require more frequent trips to the hospital and more tests than standard treatment.
Frequently Asked Questions
1. What is the difference between standard treatment and a clinical trial?
Standard treatment is a therapy that has already been proven to be effective and has been approved for general use by regulatory authorities based on the results of past clinical trials. A clinical trial, on the other hand, is a research study designed to evaluate a new treatment to see if it is safe and more effective than the current standard.
2. Who is eligible to participate in a clinical trial?
Each clinical trial has a strict set of rules, known as eligibility criteria, that define who can participate. These criteria are part of the study’s protocol and are designed to ensure patient safety and the scientific integrity of the research. Criteria often include the specific type and stage of cancer, a patient’s prior treatment history, their age, and their overall health and organ function.
3. What is a placebo and will I receive one in a cancer trial?
A placebo is an inactive substance that looks identical to the real drug being tested. The use of placebos in cancer clinical trials is very rare. It would be considered unethical to give a placebo to a patient if a known, effective standard treatment already exists. In the rare event a placebo is used in an oncology trial, it is almost always given in addition to standard therapy, not instead of it (e.g., standard chemotherapy plus a new drug vs. standard chemotherapy plus a placebo). This would be explained in full detail during the informed consent process.
4. Can I leave a clinical trial after I have joined?
Yes, absolutely. A patient’s participation in a clinical trial is completely voluntary. You have the right to withdraw from the study at any time, for any reason. Choosing to leave a trial will not affect your relationship with your doctors or your right to receive standard medical care.
5. Are there costs associated with participating in a clinical trial?
Typically, the investigational drug being studied and any extra tests or procedures required solely for the research purposes of the trial are paid for by the study sponsor (usually a pharmaceutical company). However, the costs of routine medical care—the parts of your treatment that you would receive even if you were not in the trial—are generally not covered by the sponsor. It is very important to discuss the specifics of what is covered with the clinical trial team and your insurance provider before enrolling.
6. How is patient safety monitored during a clinical trial?
Patient safety is monitored continuously and rigorously throughout a clinical trial. The research team watches patients closely for any side effects. In addition, trials are monitored by independent data and safety monitoring boards (DSMBs), as well as by the sponsoring organization and regulatory authorities, to ensure that the study continues to be safe for participants.
